Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $38.71 million. The enterprise value is $5.20 million.

Market Cap	38.71M
Enterprise Value	5.20M

Important Dates

The last earnings date was Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

MREO has 159.62 million shares outstanding. The number of shares has increased by 5.37% in one year.

Current Share Class	n/a
Shares Outstanding	159.62M
Shares Change (YoY)	+5.37%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	15.23%
Float	114.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	82.84
Forward PS	n/a
PB Ratio	1.22
P/TBV Ratio	1.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.48

Current Ratio	6.48
Quick Ratio	6.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-381.17

Financial Efficiency

Return on equity (ROE) is -75.87% and return on invested capital (ROIC) is -47.71%.

Return on Equity (ROE)	-75.87%
Return on Assets (ROA)	-41.55%
Return on Invested Capital (ROIC)	-47.71%
Return on Capital Employed (ROCE)	-105.15%
Weighted Average Cost of Capital (WACC)	5.30%
Revenue Per Employee	$12,821
Profits Per Employee	-$915,641
Employee Count	39
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -89.40% in the last 52 weeks. The beta is 0.19, so MREO's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-89.40%
50-Day Moving Average	0.32
200-Day Moving Average	1.17
Relative Strength Index (RSI)	36.14
Average Volume (20 Days)	1,662,348

Short Selling Information

The latest short interest is 6.51 million, so 5.01% of the outstanding shares have been sold short.

Short Interest	6.51M
Short Previous Month	8.27M
Short % of Shares Out	5.01%
Short % of Float	n/a
Short Ratio (days to cover)	4.04

Income Statement

In the last 12 months, MREO had revenue of $500,000 and -$35.71 million in losses. Loss per share was -$0.22.

Revenue	500,000
Gross Profit	367,000
Operating Income	-36.21M
Pretax Income	-35.71M
Net Income	-35.71M
EBITDA	-35.58M
EBIT	-36.21M
Loss Per Share	-$0.22

Balance Sheet

The company has $36.22 million in cash and n/a in debt, with a net cash position of $36.22 million or $0.23 per share.

Cash & Cash Equivalents	36.22M
Total Debt	n/a
Net Cash	36.22M
Net Cash Per Share	$0.23
Equity (Book Value)	34.05M
Book Value Per Share	0.21
Working Capital	33.86M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	633,500
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	73.40%
Operating Margin	-7,242.20%
Pretax Margin	-7,142.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.37%
Shareholder Yield	-5.37%
Earnings Yield	-86.21%
FCF Yield	n/a

Analyst Forecast

The average price target for MREO is $1.50, which is 518.56% higher than the current price. The consensus rating is "Buy".

Price Target	$1.50
Price Target Difference	518.56%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	126.61%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a